Dr. B-affiliated medical practices are independently owned and operated by licensed physicians who provide services using the Dr. B telehealth platform. Get more information about the relationship between Dr. B and the medical practices.
* Financial hardship assistance available for those who qualify
PAXLOVID and MOLNUPIRAVIR have not been approved, but have been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARSCoV-2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization or death. The emergency use of PAXLOVID and MOLNUPIRAVIR is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
